FDA approves RedHill’s drug for cancer-causing H. pylori bacterial infections
Shares of the company were up more than 13 percent on the Tel Aviv Stock Exchange following the approval of Talicia, meant to address the growing issue of the bacteria's resistance to antibiotics. H. pylori is a major cause of gastric cancer.